nach oben

Archives of Dermatological Research

Erschienen in:

27.06.2016 | Review

Oral lichen planus: a literature review and update

verfasst von: Mohammad S. Alrashdan, Nicola Cirillo, Michael McCullough

Erschienen in: Archives of Dermatological Research | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Lichen planus (LP) is a common chronic inflammatory condition that can affect skin and mucous membranes, including the oral mucosa. Because of the anatomic, physiologic and functional peculiarities of the oral cavity, the oral variant of LP (OLP) requires specific evaluations in terms of diagnosis and management. In this comprehensive review, we discuss the current developments in the understanding of the etiopathogenesis, clinical-pathologic presentation, and treatment of OLP, and provide follow-up recommendations informed by recent data on the malignant potential of the disease as well as health economics evaluations.

Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, Axell T, Bruce AJ, Carpenter W, Eisenberg E et al (2007) Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103(Suppl: S25) e21–12

Alrashdan MS, Angel C, Cirillo N, McCullough M (2016) Smoking habits and clinical patterns can alter the inflammatory infiltrate in oral lichenoid lesions. Oral Surg Oral Med Oral Pathol Oral Radiol 121:49–57PubMedCrossRef

Baccaglini L, Thongprasom K, Carrozzo M, Bigby M (2013) Urban legends series: lichen planus. Oral Dis 19:128–143PubMedCrossRef

Bagan JV, Ramon C, Gonzalez L, Diago M, Milian MA, Cors R, Lloria E, Cardona F, Jimenez Y (1998) Preliminary investigation of the association of oral lichen planus and hepatitis C. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:532–536PubMedCrossRef

Beaird LM, Kahloon N, Franco J, Fairley JA (2001) Incidence of hepatitis C in lichen planus. J Am Acad Dermatol 44:311–312PubMedCrossRef

Bellman B, Reddy RK, Falanga V (1995) Lichen planus associated with hepatitis C. Lancet 346:1234PubMedCrossRef

Bermejo-Fenoll A, Lopez-Jornet P (2006) Familial oral lichen planus: presentation of six families. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:e12–e15PubMedCrossRef

Bolewska J, Reibel J (1989) T lymphocytes, langerhans cells and HLA-DR expression on keratinocytes in oral lesions associated with amalgam restorations. J Oral Pathol Med 18:525–528PubMedCrossRef

Bornstein MM, Kalas L, Lemp S, Altermatt HJ, Rees TD, Buser D (2006) Oral lichen planus and malignant transformation: a retrospective follow-up study of clinical and histopathologic data. Quintessence Int 37:261–271PubMed

10.

Brown GR, Lindberg G, Meddings J, Silva M, Beutler B, Thiele D (1999) Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease. Gastroenterology 116:593–601PubMedCrossRef

11.

Burkhart NW, Burkes EJ, Burker EJ (1997) Meeting the educational needs of patients with oral lichen planus. Gen Dent 45:126–132 (quiz 143–124) PubMed

12.

Carbone M, Conrotto D, Carrozzo M, Broccoletti R, Gandolfo S, Scully C (1999) Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis 5:44–49PubMedCrossRef

13.

Carbone M, Goss E, Carrozzo M, Castellano S, Conrotto D, Broccoletti R, Gandolfo S (2003) Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med 32:323–329PubMedCrossRef

14.

Carrozzo M, Francia Di Celle P, Gandolfo S, Carbone M, Conrotto D, Fasano ME, Roggero S, Rendine S, Ghisetti V (2001) Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus-associated oral lichen planus. Br J Dermatol 144:803–808PubMedCrossRef

15.

Carrozzo M, Gandolfo S, Carbone M, Colombatto P, Broccoletti R, Garzino-Demo P, Ghisetti V (1996) Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med 25:527–533PubMedCrossRef

16.

Carrozzo M, Uboldi de Capei M, Dametto E, Fasano ME, Arduino P, Broccoletti R, Vezza D, Rendine S, Curtoni ES, Gandolfo S (2004) Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol 122:87–94PubMedCrossRef

17.

Chamani G, Rad M, Zarei MR, Lotfi S, Sadeghi M, Ahmadi Z (2015) Efficacy of tacrolimus and clobetasol in the treatment of oral lichen planus: a systematic review and meta-analysis. Int J Dermatol 54:996–1004PubMedCrossRef

18.

Clevers H (2004) At the crossroads of inflammation and cancer. Cell 118:671–674PubMedCrossRef

19.

Constant SL, Bottomly K (1997) Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 15:297–322PubMedCrossRef

20.

Cottoni F, Tedde G, Solinas A, Deplano A (1991) Lichen planus associated with anti-liver-kidney microsome-positive chronic active hepatitis and hyperthyroidism. Arch Dermatol 127:1730–1731PubMedCrossRef

21.

Cribier B, Garnier C, Laustriat D, Heid E (1994) Lichen planus and hepatitis C virus infection: an epidemiologic study. J Am Acad Dermatol 31:1070–1072PubMedCrossRef

22.

Dalmau J, Puig L, Roe E, Peramiquel L, Campos M, Alomar A (2007) Successful treatment of oral erosive lichen planus with mycophenolate mofetil. J Eur Acad Dermatol Venereol 21:259–260PubMed

23.

Daramola OO, George AO, Ogunbiyi AO (2002) Hepatitis C virus and lichen planus in Nigerians: any relationship? Int J Dermatol 41:217–219PubMedCrossRef

24.

Dupin N, Chosidow O, Lunel F, Fretz C, Szpirglas H, Frances C (1997) Oral lichen planus and hepatitis C virus infection: a fortuitous association? Arch Dermatol 133:1052–1053PubMedCrossRef

25.

Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom K (2005) Number V oral lichen planus: clinical features and management. Oral Dis 11:338–349PubMedCrossRef

26.

Eisenberg E (2000) Oral lichen planus: a benign lesion. J Oral Maxillofac Surg 58:1278–1285PubMedCrossRef

27.

Epstein JB, Wan LS, Gorsky M, Zhang L (2003) Oral lichen planus: progress in understanding its malignant potential and the implications for clinical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96:32–37PubMedCrossRef

28.

Erkek E, Bozdogan O, Olut AI (2001) Hepatitis C virus infection prevalence in lichen planus: examination of lesional and normal skin of hepatitis C virus-infected patients with lichen planus for the presence of hepatitis C virus RNA. Clin Exp Dermatol 26:540–544PubMedCrossRef

29.

Fang KC, Raymond WW, Blount JL, Caughey GH (1997) Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J Biol Chem 272:25628–25635PubMedCrossRef

30.

Farhi D, Dupin N (2010) Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies. Clin Dermatol 28:100–108PubMedCrossRef

31.

Farthing PM, Cruchley AT (1989) Expression of MHC class II antigens (HLA DR, DP and DQ) by keratinocytes in oral lichen planus. J Oral Pathol Med 18:305–309PubMedCrossRef

32.

Farthing PM, Matear P, Cruchley AT (1990) The activation of Langerhans cells in oral lichen planus. J Oral Pathol Med 19:81–85PubMedCrossRef

33.

Gale NPB, D Sidransky, Gale N, Pilch BZ, Sidransky D (2005) Epithelial precursor lesions. In: Evenson JW, Reichart P, Sidransky D (eds) Barnes L. Pathology and genetics. Head and neck tumours. IARC, Lyon, pp 177–181

34.

Gonzalez-Moles MA, Scully C, Gil-Montoya JA (2008) Oral lichen planus: controversies surrounding malignant transformation. Oral Dis 14:229–243PubMedCrossRef

35.

Grinspan D, Diaz J, Villapol LO, Schneiderman J, Berdichesky R, Palese D, Faerman J (1966) Lichen ruber planus of the buccal mucosa. Its association with diabetes. Bull Soc Fr Dermatol Syphiligr 73:898–899PubMed

36.

Helander SD, Rogers RS 3rd (1994) The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes. J Am Acad Dermatol 30:65–75PubMedCrossRef

37.

Henriksson E, Mattsson U, Hakansson J (1995) Healing of lichenoid reactions following removal of amalgam. A clinical follow-up. J Clin Periodontol 22:287–294PubMedCrossRef

38.

Herve P, Flesch M, Tiberghien P, Wijdenes J, Racadot E, Bordigoni P, Plouvier E, Stephan JL, Bourdeau H, Holler E et al (1992) Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease. Blood 79:3362–3368PubMed

39.

Ibrahim HA, Baddour MM, Morsi MG, Abdelkader AA (1999) Should we routinely check for hepatitis B and C in patients with lichen planus or cutaneous vasculitis? East Mediterr Health J 5:71–78PubMed

40.

Ichimura M, Hiratsuka K, Ogura N, Utsunomiya T, Sakamaki H, Kondoh T, Abiko Y, Otake S, Yamamoto M (2006) Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus. J Oral Pathol Med 35:167–174PubMedCrossRef

41.

Imanguli MM, Alevizos I, Brown R, Pavletic SZ, Atkinson JC (2008) Oral graft-versus-host disease. Oral Dis 14:396–412PubMedPubMedCentralCrossRef

42.

Ingafou M, Porter SR, Scully C, Teo CG (1998) No evidence of HCV infection or liver disease in British patients with oral lichen planus. Int J Oral Maxillofac Surg 27:65–66PubMedCrossRef

43.

Ishii T (1987) Immunohistochemical demonstration of T cell subsets and accessory cells in oral lichen planus. J Oral Pathol 16:356–361PubMedCrossRef

44.

Ismail SB, Kumar SK, Zain RB (2007) Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 49:89–106PubMedCrossRef

45.

Issa Y, Brunton PA, Glenny AM, Duxbury AJ (2004) Healing of oral lichenoid lesions after replacing amalgam restorations: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98:553–565PubMedCrossRef

46.

Ivanovski K, Nakova M, Warburton G, Pesevska S, Filipovska A, Nares S, Nunn ME, Angelova D, Angelov N (2005) Psychological profile in oral lichen planus. J Clin Periodontol 32:1034–1040PubMedCrossRef

47.

Jose M, Raghu AR, Rao NN (2001) Evaluation of mast cells in oral lichen planus and oral lichenoid reaction. Indian J Dent Res 12:175–179PubMed

48.

Juneja M, Mahajan S, Rao NN, George T, Boaz K (2006) Histochemical analysis of pathological alterations in oral lichen planus and oral lichenoid lesions. J Oral Sci 48:185–193PubMedCrossRef

49.

Kanwar AJ, De D (2010) Lichen planus in childhood: report of 100 cases. Clin Exp Dermatol 35:257–262PubMedCrossRef

50.

Koray M, Dulger O, Ak G, Horasanli S, Ucok A, Tanyeri H, Badur S (2003) The evaluation of anxiety and salivary cortisol levels in patients with oral lichen planus. Oral Dis 9:298–301PubMedCrossRef

51.

Kramer IR, Lucas RB, Pindborg JJ, Sobin LH (1978) Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 46:518–539PubMedCrossRef

52.

Krutchkoff DJ, Eisenberg E (1985) Lichenoid dysplasia: a distinct histopathologic entity. Oral Surg Oral Med Oral Pathol 60:308–315PubMedCrossRef

53.

Laine J, Kalimo K, Forssell H, Happonen RP (1992) Resolution of oral lichenoid lesions after replacement of amalgam restorations in patients allergic to mercury compounds. Br J Dermatol 126:10–15PubMedCrossRef

54.

Lajevardi V, Ghodsi SZ, Hallaji Z, Shafiei Z, Aghazadeh N, Akbari Z (2016) Treatment of erosive oral lichen planus with methotrexate. J Dtsch Dermatol Ges 14:286–293PubMed

55.

Lind PO, Hurlen B, Lyberg T, Aas E (1986) Amalgam-related oral lichenoid reaction. Scand J Dent Res 94:448–451PubMed

56.

Lo Muzio L, Mignogna MD, Favia G, Procaccini M, Testa NF, Bucci E (1998) The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. Oral Oncol 34:239–246PubMedCrossRef

57.

Lodi G, Giuliani M, Majorana A, Sardella A, Bez C, Demarosi F, Carrassi A (2004) Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol 151:1172–1181PubMedCrossRef

58.

Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K (2005) Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:40–51PubMedCrossRef

59.

Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K (2005) Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100:164–178PubMedCrossRef

60.

Mergoni G, Ergun S, Vescovi P, Mete O, Tanyeri H, Meleti M (2011) Oral postinflammatory pigmentation: an analysis of 7 cases. Med Oral Patol Oral Cir Bucal 16:e11–e14PubMedCrossRef

61.

Merry R, Belfield L, McArdle P, McLennan A, Crean S, Foey A (2012) Oral health and pathology: a macrophage account. Br J Oral Maxillofac Surg 50:2–7PubMedCrossRef

62.

Mignogna MD, Fedele S, Lo Russo L (2006) Dysplasia/neoplasia surveillance in oral lichen planus patients: a description of clinical criteria adopted at a single centre and their impact on prognosis. Oral Oncol 42:819–824PubMedCrossRef

63.

Mignogna MD, Fedele S, Lo Russo L, Lo Muzio L, Bucci E (2004) Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence? Oral Oncol 40:120–130PubMedCrossRef

64.

Mignogna MD, Lo Muzio L, Lo Russo L, Fedele S, Ruoppo E, Bucci E (2001) Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5-year experience. Oral Oncol 37:262–267PubMedCrossRef

65.

Mignogna MD, Lo Russo L, Fedele S (2005) Gingival involvement of oral lichen planus in a series of 700 patients. J Clin Periodontol 32:1029–1033PubMedCrossRef

66.

Mignogna MD, Lo Russo L, Fedele S, Ruoppo E, Califano L, Lo Muzio L (2002) Clinical behaviour of malignant transforming oral lichen planus. Eur J Surg Oncol 28:838–843PubMedCrossRef

67.

Mokni M, Rybojad M, Puppin D Jr, Catala S, Venezia F, Djian R, Morel P (1991) Lichen planus and hepatitis C virus. J Am Acad Dermatol 24:792PubMedCrossRef

68.

Nagao Y, Sata M, Tanikawa K, Itoh K, Kameyama T (1995) Lichen planus and hepatitis C virus in the northern Kyushu region of Japan. Eur J Clin Invest 25:910–914PubMedCrossRef

69.

O’Neill ID, Scully C (2013) Biologics in oral medicine: ulcerative disorders. Oral Dis 19:37–45PubMedCrossRef

70.

Parashar P (2011) Oral lichen planus. Otolaryngol Clin North Am 44:89–107 (vi) PubMedCrossRef

71.

Payeras MR, Cherubini K, Figueiredo MA, Salum FG (2013) Oral lichen planus: focus on etiopathogenesis. Arch Oral Biol 58:1057–1069PubMedCrossRef

72.

Quispel R, van Boxel OS, Schipper ME, Sigurdsson V, Canninga-van Dijk MR, Kerckhoffs A, Smout AJ, Samsom M, Schwartz MP (2009) High prevalence of esophageal involvement in lichen planus: a study using magnification chromoendoscopy. Endoscopy 41:187–193PubMedCrossRef

73.

Rojo-Moreno JL, Bagan JV, Rojo-Moreno J, Donat JS, Milian MA, Jimenez Y (1998) Psychologic factors and oral lichen planus. A psychometric evaluation of 100 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86:687–691PubMedCrossRef

74.

Roopashree MR, Gondhalekar RV, Shashikanth MC, George J, Thippeswamy SH, Shukla A (2010) Pathogenesis of oral lichen planus—a review. J Oral Pathol Med 39:729–734PubMedCrossRef

75.

Rubaci AH, Kazancioglu HO, Olgac V, Ak G (2012) The roles of matrix metalloproteinases-2, -7, -10 and tissue inhibitor of metalloproteinase-1 in the pathogenesis of oral lichen planus. J Oral Pathol Med 41:689–696PubMedCrossRef

76.

Santoro A, Majorana A, Bardellini E, Festa S, Sapelli P, Facchetti F (2003) NF-kappaB expression in oral and cutaneous lichen planus. J Pathol 201:466–472PubMedCrossRef

77.

Savage NW, McCullough MJ (2005) Topical corticosteroids in dental practice. Aust Dent J 50:S40–S44PubMedCrossRef

78.

Scully C, Beyli M, Ferreiro MC, Ficarra G, Gill Y, Griffiths M, Holmstrup P, Mutlu S, Porter S, Wray D (1998) Update on oral lichen planus: etiopathogenesis and management. Crit Rev Oral Biol Med 9:86–122PubMedCrossRef

79.

Scully C, Carrozzo M (2008) Oral mucosal disease: lichen planus. Br J Oral Maxillofac Surg 46:15–21PubMedCrossRef

80.

Scully C, Diz Dios P (2001) Orofacial effects of antiretroviral therapies. Oral Dis 7:205–210PubMedCrossRef

81.

Siponen M, Huuskonen L, Laara E, Salo T (2010) Association of oral lichen planus with thyroid disease in a Finnish population: a retrospective case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110:319–324PubMedCrossRef

82.

Skoglund A, Egelrud T (1991) Hypersensitivity reactions to dental materials in patients with lichenoid oral mucosal lesions and in patients with burning mouth syndrome. Scand J Dent Res 99:320–328PubMed

83.

Soto Araya M, Rojas Alcayaga G, Esguep A (2004) Association between psychological disorders and the presence of Oral lichen planus, Burning mouth syndrome and Recurrent aphthous stomatitis. Med Oral 9:1–7PubMedCrossRef

84.

Sugerman PB, Savage NW, Walsh LJ, Zhao ZZ, Zhou XJ, Khan A, Seymour GJ, Bigby M (2002) The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med 13:350–365PubMedCrossRef

85.

Thongprasom K, Dhanuthai K (2008) Steriods in the treatment of lichen planus: a review. J Oral Sci 50:377–385PubMedCrossRef

86.

Thongprasom K, Luengvisut P, Wongwatanakij A, Boonjatturus C (2003) Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up. J Oral Pathol Med 32:315–322PubMedCrossRef

87.

Thongprasom K, Prapinjumrune C, Carrozzo M (2013) Novel therapies for oral lichen planus. J Oral Pathol Med 42:721–727PubMedCrossRef

88.

Thornhill MH, Pemberton MN, Simmons RK, Theaker ED (2003) Amalgam-contact hypersensitivity lesions and oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:291–299PubMedCrossRef

89.

van der Meij EH, Bezemer PD, van der Waal I (2002) Cost-effectiveness of screening for the possible development of cancer in patients with oral lichen planus. Community Dent Oral Epidemiol 30:342–351PubMedCrossRef

90.

van der Meij EH, Mast H, van der Waal I (2007) The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective 5-year follow-up study of 192 patients. Oral Oncol 43:742–748PubMedCrossRef

91.

van der Meij EH, Schepman KP, Smeele LE, van der Wal JE, Bezemer PD, van der Waal I (1999) A review of the recent literature regarding malignant transformation of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:307–310PubMedCrossRef

92.

van der Meij EH, Schepman KP, van der Waal I (2003) The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96:164–171PubMedCrossRef

93.

van der Meij EH, van der Waal I (2003) Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med 32:507–512PubMedCrossRef

94.

Villarroel Dorrego M, Correnti M, Delgado R, Tapia FJ (2002) Oral lichen planus: immunohistology of mucosal lesions. J Oral Pathol Med 31:410–414PubMedCrossRef

95.

Walton LJ, Macey MG, Thornhill MH, Farthing PM (1998) Intra-epithelial subpopulations of T lymphocytes and Langerhans cells in oral lichen planus. J Oral Pathol Med 27:116–123PubMedCrossRef

96.

Wee JS, Shirlaw PJ, Challacombe SJ, Setterfield JF (2012) Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients. Br J Dermatol 167:36–43PubMedCrossRef

97.

Xie S, Ding L, Xiong Z, Zhu S (2012) Implications of Th1 and Th17 cells in pathogenesis of oral lichen planus. J Huazhong Univ Sci Technolog Med Sci 32:451–457PubMedCrossRef

98.

Zhao ZZ, Savage NW, Pujic Z, Walsh LJ (1997) Immunohistochemical localization of mast cells and mast cell-nerve interactions in oral lichen planus. Oral Dis 3:71–76PubMedCrossRef

99.

Zhou XJ, Sugerman PB, Savage NW, Walsh LJ (2001) Matrix metalloproteinases and their inhibitors in oral lichen planus. J Cutan Pathol 28:72–82PubMedCrossRef

100.

Firth FA, Friedlander LT, Parachuru VP, Kardos TB, Seymour GJ, Rich AM (2015) Regulation of immune cells in oral lichen planus. Arch Dermatol Res 307:333–339PubMedCrossRef

101.

Nogueira MA, Gavioli CF, Pereira NZ, de Carvalho GC, Domingues R, Aoki V, Sato MN (2015) Human endogenous retrovirus expression is inversely related with the up-regulation of interferon-inducible genes in the skin of patients with lichen planus. Arch Dermatol Res 307:259–264PubMedCrossRef

102.

Shen Z, Gao X, Ma L, Zhou Z, Shen X, Liu W (2014) Expression of Foxp3 and interleukin-17 in lichen planus lesions with emphasis on difference in oral and cutaneous variants. Arch Dermatol Res 306:441–446PubMedCrossRef

Titel: Oral lichen planus: a literature review and update
verfasst von: Mohammad S. Alrashdan
Nicola Cirillo
Michael McCullough
Publikationsdatum: 27.06.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Dermatological Research / Ausgabe 8/2016
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI: https://doi.org/10.1007/s00403-016-1667-2

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

22.04.2024 | DGIM 2024 | Nachrichten

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Oral lichen planus: a literature review and update

Abstract

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2016

Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase

Bed bugs and possible transmission of human pathogens: a systematic review

A synthetic C16 omega-hydroxyphytoceramide improves skin barrier functions from diversely perturbed epidermal conditions

Decreased PD-1 positive blood follicular helper T cells in patients with psoriasis

Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus

Pleiotrophin is downregulated in human keloids

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie